...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: you won’t see anyone buying this

"As I see it, if a deal of any kind happens to fall in our laps dilution is immaterial, especially to the shareholders that paid a few pennies for "ZHCLF" shares"

"dilution is immaterial"??? it's all relavent/material koo!  

Burying one's head in sand & saying it's ok because of what the shares were once worth is insane. Being content or trying too justify mediocrity doesn't sit well with me.

Share
New Message
Please login to post a reply